1034-10-2 Usage
Uses
Used in Research Applications:
DL-Thyronine is used as a research compound for investigating thyroid hormone function, metabolism, and thyroid-related diseases. Its synthetic nature enables researchers to study the effects of thyroid hormone analogs on various physiological processes, providing valuable insights into thyroid biology.
Used in Pharmaceutical Industry:
DL-Thyronine is used as a potential therapeutic agent for the treatment of thyroid-related disorders. Its structural similarity to naturally occurring thyroid hormones allows it to potentially modulate thyroid hormone levels and influence related metabolic pathways, offering a potential avenue for the development of novel treatments for thyroid dysfunction.
Used in Diagnostic Applications:
DL-Thyronine can be used as a diagnostic tool in the assessment of thyroid function. Its ability to interact with thyroid hormone receptors and influence metabolic processes can help in the identification and monitoring of thyroid-related conditions, aiding in the diagnosis and management of these diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 1034-10-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,0,3 and 4 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1034-10:
(6*1)+(5*0)+(4*3)+(3*4)+(2*1)+(1*0)=32
32 % 10 = 2
So 1034-10-2 is a valid CAS Registry Number.
InChI:InChI=1/C15H15NO4/c16-14(15(18)19)9-10-1-5-12(6-2-10)20-13-7-3-11(17)4-8-13/h1-8,14,17H,9,16H2,(H,18,19)/t14-/m0/s1
1034-10-2Relevant articles and documents
BIOTINYLATED THYROXINE
-
, (2010/04/23)
A means for conveniently and accurately measuring thyroxine or thyronine present in the blood or the like is provided: a compound represented by general formula (I) below: wherein L represents a linear or branched-chain linker having 5 to 50 total atoms; X represents one or more thyroxines, thyronines, or residues of derivatives thereof, bound to the main chain and/or side chain of the linker represented by L, a conjugate in the form of the above compound bonded to an avidin protein, and an aqueous dispersion including a microparticles the surface of which is modified with the above conjugate.